| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.569 | 0.011 | 0.571 | GABA C receptor rho-3 antagonist | 0.558 0.013 DB12243 0.412 0.056 DBMET00003 0.571 0.011 DBMET00004 0.412 0.056 DBMET01588 | DBMET00004 | |
| 0.514 | 0.045 | 0.514 | Analgesic | |||
| 0.45 | 0.003 | 0.45 | Ferrochelatase inhibitor | 0.338 0.005 DB12243 0.348 0.005 DBMET00003 0.271 0.01 DBMET00004 0.348 0.005 DBMET01588 | ||
| 0.459 | 0.026 | 0.459 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.201 0.099 DB12243 0.247 0.079 DBMET00003 0.441 0.029 DBMET00004 0.247 0.079 DBMET01588 | ||
| 0.468 | 0.035 | 0.468 | Thioredoxin glutathione reductase inhibitor | 0.208 0.166 DBMET00003 0.204 0.17 DBMET00004 0.208 0.166 DBMET01588 | ||
| 0.514 | 0.083 | 0.514 | DNA polymerase beta inhibitor | 0.469 0.095 DB12243 0.239 0.199 DBMET00003 0.239 0.199 DBMET01588 | ||
| 0.501 | 0.074 | 0.501 | Beta lactamase inhibitor | 0.344 0.117 DB12243 0.256 0.154 DBMET00004 | ||
| 0.46 | 0.055 | 0.525 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.525 0.024 DB12243 0.362 0.138 DBMET00003 0.376 0.123 DBMET00004 0.362 0.138 DBMET01588 | DB12243 | |
| 0.483 | 0.085 | 0.529 | Alpha-glucosidase inhibitor | 0.529 0.072 DB12243 0.343 0.139 DBMET00003 0.396 0.117 DBMET00004 0.343 0.139 DBMET01588 | DB12243 | |
| 0.478 | 0.089 | 0.478 | DNA directed DNA polymerase inhibitor | 0.456 0.095 DB12243 0.274 0.176 DBMET00003 0.274 0.176 DBMET01588 | ||
| 0.433 | 0.047 | 0.439 | Thyroid hormone antagonist | 0.439 0.045 DB12243 0.277 0.106 DBMET00003 0.186 0.174 DBMET00004 0.277 0.106 DBMET01588 | DB12243 | |
| 0.413 | 0.05 | 0.436 | Thyroid hormone beta antagonist | 0.436 0.044 DB12243 0.253 0.116 DBMET00003 0.253 0.116 DBMET01588 | DB12243 | |
| 0.461 | 0.105 | 0.587 | Antiinflammatory | 0.417 0.129 DB12243 0.587 0.057 DBMET00003 0.587 0.057 DBMET01588 | DBMET01588 | |
| 0.392 | 0.078 | 0.392 | 15-Lipoxygenase inhibitor | 0.262 0.155 DB12243 0.217 0.194 DBMET00004 | ||
| 0.325 | 0.023 | 0.325 | Non-steroidal antiinflammatory agent | 0.236 0.049 DB12243 0.269 0.036 DBMET00003 0.264 0.037 DBMET00004 0.269 0.036 DBMET01588 | ||
| 0.306 | 0.012 | 0.306 | NADPH oxidase inhibitor | 0.137 0.064 DB12243 0.19 0.038 DBMET00003 0.265 0.018 DBMET00004 0.19 0.038 DBMET01588 | ||
| 0.38 | 0.095 | 0.635 | Calcium channel L-type activator | 0.414 0.072 DB12243 0.635 0.004 DBMET00003 0.44 0.056 DBMET00004 0.635 0.004 DBMET01588 | DBMET01588 | |
| 0.327 | 0.044 | 0.337 | Insulysin inhibitor | 0.266 0.082 DB12243 0.296 0.061 DBMET00003 0.337 0.039 DBMET00004 0.296 0.061 DBMET01588 | DBMET00004 | |
| 0.253 | 0.005 | 0.253 | Hepatocyte growth factor antagonist | 0.202 0.01 DBMET00003 0.12 0.035 DBMET00004 0.202 0.01 DBMET01588 | ||
| 0.247 | 0.005 | 0.247 | Prostaglandin E2 antagonist | |||
| 0.341 | 0.123 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.48 0.039 DB12243 0.275 0.195 DBMET00003 0.353 0.113 DBMET00004 0.275 0.195 DBMET01588 | DB12243 | |
| 0.237 | 0.032 | 0.237 | Histone acetyltransferase inhibitor | 0.223 0.041 DB12243 0.184 0.094 DBMET00003 0.221 0.043 DBMET00004 0.184 0.094 DBMET01588 | ||
| 0.338 | 0.135 | 0.437 | Transcription factor inhibitor | 0.437 0.096 DB12243 | DB12243 | |
| 0.218 | 0.021 | 0.224 | GABA C receptor rho-2 antagonist | 0.224 0.018 DB12243 0.168 0.053 DBMET00003 0.207 0.025 DBMET00004 0.168 0.053 DBMET01588 | DB12243 | |
| 0.243 | 0.051 | 0.243 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.156 0.09 DBMET00003 0.156 0.09 DBMET01588 | ||
| 0.217 | 0.028 | 0.392 | Cyclooxygenase 1 inhibitor | 0.392 0.007 DB12243 0.163 0.05 DBMET00003 0.157 0.053 DBMET00004 0.163 0.05 DBMET01588 | DB12243 | |
| 0.332 | 0.149 | 0.332 | MAP kinase 1 inhibitor | 0.25 0.233 DB12243 | ||
| 0.209 | 0.029 | 0.209 | Hemostatic | 0.122 0.111 DB12243 0.151 0.067 DBMET00003 0.151 0.067 DBMET01588 | ||
| 0.19 | 0.018 | 0.191 | 5 Hydroxytryptamine 3A agonist | 0.191 0.018 DB12243 0.166 0.028 DBMET00004 | DB12243 | |
| 0.242 | 0.076 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.267 0.053 DB12243 0.228 0.092 DBMET00003 0.28 0.044 DBMET00004 0.228 0.092 DBMET01588 | DBMET00004 | |
| 0.248 | 0.083 | 0.26 | 5 Hydroxytryptamine uptake stimulant | 0.238 0.094 DB12243 0.248 0.083 DBMET00003 0.26 0.071 DBMET00004 0.248 0.083 DBMET01588 | DBMET00004 | |
| 0.246 | 0.084 | 0.261 | Gastrin inhibitor | 0.194 0.159 DB12243 0.261 0.067 DBMET00003 0.261 0.067 DBMET01588 | DBMET01588 | |
| 0.246 | 0.086 | 0.246 | Transcription factor STAT3 inhibitor | |||
| 0.221 | 0.07 | 0.221 | Anticonvulsant | 0.164 0.112 DB12243 0.181 0.098 DBMET00003 0.181 0.098 DBMET01588 | ||
| 0.187 | 0.038 | 0.205 | Mannose-6-phosphate isomerase inhibitor | 0.205 0.028 DB12243 0.179 0.043 DBMET00003 0.205 0.028 DBMET00004 0.179 0.043 DBMET01588 | DBMET00004 | |
| 0.166 | 0.018 | 0.229 | Creatine kinase inhibitor | 0.162 0.019 DB12243 0.167 0.018 DBMET00003 0.229 0.007 DBMET00004 0.167 0.018 DBMET01588 | DBMET00004 | |
| 0.188 | 0.047 | 0.335 | Cyclooxygenase inhibitor | 0.335 0.013 DB12243 0.137 0.081 DBMET00003 0.174 0.054 DBMET00004 0.137 0.081 DBMET01588 | DB12243 | |
| 0.159 | 0.021 | 0.159 | Sphingosine 1-phosphate receptor 2 agonist | 0.104 0.09 DB12243 | ||
| 0.242 | 0.108 | 0.242 | Hypoxia-inducible factor 1 alpha inhibitor | 0.193 0.16 DBMET00003 0.193 0.16 DBMET01588 | ||
| 0.239 | 0.11 | 0.291 | Streptokinase A inhibitor | 0.291 0.083 DB12243 | DB12243 | |
| 0.198 | 0.071 | 0.198 | Focal adhesion kinase 2 inhibitor | 0.182 0.085 DB12243 0.159 0.117 DBMET00004 | ||
| 0.248 | 0.125 | 0.248 | Angiogenesis inhibitor | |||
| 0.151 | 0.04 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 DB12243 0.149 0.044 DBMET00003 0.156 0.031 DBMET00004 0.149 0.044 DBMET01588 | DBMET00004 | |
| 0.115 | 0.005 | 0.115 | Corticotropin releasing factor 2 receptor antagonist | 0.088 0.011 DB12243 0.061 0.045 DBMET00003 0.091 0.01 DBMET00004 0.061 0.045 DBMET01588 | ||
| 0.15 | 0.041 | 0.225 | Cystathionine beta-synthase inhibitor | 0.108 0.068 DB12243 0.145 0.043 DBMET00003 0.225 0.019 DBMET00004 0.145 0.043 DBMET01588 | DBMET00004 | |
| 0.22 | 0.112 | 0.22 | Transcription factor STAT inhibitor | |||
| 0.251 | 0.146 | 0.295 | Calcium channel activator | 0.295 0.097 DB12243 0.241 0.158 DBMET00003 0.241 0.157 DBMET00004 0.241 0.158 DBMET01588 | DB12243 | |
| 0.155 | 0.052 | 0.284 | Alpha-N-acetylglucosaminidase inhibitor | 0.186 0.038 DB12243 0.284 0.018 DBMET00003 0.155 0.052 DBMET00004 0.284 0.018 DBMET01588 | DBMET01588 | |
| 0.124 | 0.021 | 0.131 | Bromodomain-containing protein 2 inhibitor | 0.131 0.017 DB12243 0.084 0.067 DBMET00003 0.096 0.045 DBMET00004 0.084 0.067 DBMET01588 | DB12243 | |
| 0.135 | 0.032 | 0.2 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.173 0.021 DB12243 0.2 0.016 DBMET00003 0.132 0.033 DBMET00004 0.2 0.016 DBMET01588 | DBMET01588 | |
| 0.188 | 0.086 | 0.194 | 5 Hydroxytryptamine 3E antagonist | 0.194 0.073 DB12243 | DB12243 | |
| 0.142 | 0.041 | 0.143 | Sphingosine 1-phosphate receptor 4 antagonist | 0.143 0.04 DB12243 0.136 0.048 DBMET00003 0.136 0.048 DBMET01588 | DB12243 | |
| 0.196 | 0.097 | 0.282 | Cyclic AMP phosphodiesterase inhibitor | 0.282 0.049 DB12243 0.233 0.073 DBMET00003 0.2 0.094 DBMET00004 0.233 0.073 DBMET01588 | DB12243 | |
| 0.148 | 0.05 | 0.157 | Cyclooxygenase 3 inhibitor | 0.128 0.069 DBMET00003 0.157 0.043 DBMET00004 0.128 0.069 DBMET01588 | DBMET00004 | |
| 0.152 | 0.058 | 0.152 | Alkaline phosphatase inhibitor | 0.107 0.104 DBMET00003 0.107 0.104 DBMET01588 | ||
| 0.112 | 0.019 | 0.151 | Benzodiazepine agonist | 0.151 0.008 DB12243 0.103 0.024 DBMET00003 0.103 0.024 DBMET01588 | DB12243 | |
| 0.123 | 0.037 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 DB12243 0.101 0.061 DBMET00003 0.113 0.047 DBMET00004 0.101 0.061 DBMET01588 | DB12243 | |
| 0.161 | 0.075 | 0.186 | Arachidonic acid antagonist | 0.186 0.048 DB12243 0.147 0.092 DBMET00003 0.18 0.054 DBMET00004 0.147 0.092 DBMET01588 | DB12243 | |
| 0.088 | 0.019 | 0.088 | Glutamate (mGluR7) antagonist | 0.079 0.029 DB12243 0.074 0.035 DBMET00003 0.083 0.024 DBMET00004 0.074 0.035 DBMET01588 | ||
| 0.235 | 0.167 | 0.382 | Histamine release inhibitor | 0.382 0.085 DB12243 0.33 0.109 DBMET00003 0.3 0.124 DBMET00004 0.33 0.109 DBMET01588 | DB12243 | |
| 0.133 | 0.067 | 0.267 | M17 leucyl aminopeptidase inhibitor | 0.267 0.017 DB12243 | DB12243 | |
| 0.148 | 0.082 | 0.186 | Cyclin-dependent kinase 8 inhibitor | 0.186 0.046 DB12243 0.122 0.114 DBMET00003 0.147 0.082 DBMET00004 0.122 0.114 DBMET01588 | DB12243 | |
| 0.133 | 0.068 | 0.14 | Sphingosine 1-phosphate receptor 2 antagonist | 0.14 0.055 DB12243 0.135 0.065 DBMET00004 | DB12243 | |
| 0.136 | 0.072 | 0.136 | Toll-Like receptor 9 antagonist | |||
| 0.159 | 0.096 | 0.185 | Succinate dehydrogenase inhibitor | 0.185 0.062 DB12243 0.173 0.076 DBMET00003 0.181 0.066 DBMET00004 0.173 0.076 DBMET01588 | DB12243 | |
| 0.115 | 0.054 | 0.142 | Interleukin 2 antagonist | 0.142 0.023 DB12243 | DB12243 | |
| 0.116 | 0.056 | 0.116 | Acetylcholine release stimulant | 0.109 0.069 DB12243 | ||
| 0.188 | 0.13 | 0.195 | Spasmolytic | 0.195 0.124 DBMET00003 0.195 0.124 DBMET01588 | DBMET01588 | |
| 0.094 | 0.039 | 0.15 | Porphobilinogen synthase inhibitor | 0.143 0.022 DB12243 0.101 0.035 DBMET00003 0.15 0.02 DBMET00004 0.101 0.035 DBMET01588 | DBMET00004 | |
| 0.206 | 0.153 | 0.206 | Prostaglandin dehydrogenase inhibitor | |||
| 0.202 | 0.149 | 0.293 | 12-Lipoxygenase inhibitor | 0.253 0.107 DB12243 0.293 0.084 DBMET00004 | DBMET00004 | |
| 0.167 | 0.114 | 0.207 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.144 DB12243 0.207 0.067 DBMET00003 0.198 0.073 DBMET00004 0.207 0.067 DBMET01588 | DBMET01588 | |
| 0.151 | 0.099 | 0.179 | Tumour necrosis factor antagonist | 0.179 0.068 DB12243 | DB12243 | |
| 0.112 | 0.061 | 0.142 | GABA C receptor antagonist | 0.142 0.035 DB12243 0.094 0.087 DBMET00003 0.115 0.058 DBMET00004 0.094 0.087 DBMET01588 | DB12243 | |
| 0.103 | 0.054 | 0.106 | Electrolyte absorption antagonist | 0.106 0.049 DB12243 0.089 0.077 DBMET00003 0.094 0.067 DBMET00004 0.089 0.077 DBMET01588 | DB12243 | |
| 0.104 | 0.057 | 0.167 | UDP-glucose 4-epimerase inhibitor | 0.12 0.043 DB12243 0.167 0.024 DBMET00003 0.126 0.039 DBMET00004 0.167 0.024 DBMET01588 | DBMET01588 | |
| 0.167 | 0.123 | 0.167 | Aryl hydrocarbon receptor agonist | |||
| 0.068 | 0.027 | 0.068 | Prostaglandin antagonist | |||
| 0.147 | 0.109 | 0.171 | Lipocortins synthesis antagonist | 0.164 0.087 DB12243 0.136 0.128 DBMET00003 0.171 0.079 DBMET00004 0.136 0.128 DBMET01588 | DBMET00004 | |
| 0.102 | 0.065 | 0.114 | Adenylate kinase inhibitor | 0.106 0.058 DB12243 0.114 0.049 DBMET00003 0.105 0.06 DBMET00004 0.114 0.049 DBMET01588 | DBMET01588 | |
| 0.175 | 0.139 | 0.191 | Nitric-oxide synthase stimulant | 0.191 0.105 DB12243 0.184 0.12 DBMET00003 0.186 0.115 DBMET00004 0.184 0.12 DBMET01588 | DB12243 | |
| 0.096 | 0.06 | 0.099 | Phosphodiesterase 6D inhibitor | 0.094 0.064 DBMET00003 0.099 0.054 DBMET00004 0.094 0.064 DBMET01588 | DBMET00004 | |
| 0.118 | 0.082 | 0.295 | Cyclooxygenase 2 inhibitor | 0.295 0.014 DB12243 0.121 0.079 DBMET00004 | DB12243 | |
| 0.085 | 0.049 | 0.116 | CC chemokine 5 receptor agonist | 0.116 0.01 DB12243 0.088 0.041 DBMET00004 | DB12243 | |
| 0.178 | 0.143 | 0.18 | 5 Hydroxytryptamine release stimulant | 0.18 0.14 DB12243 0.177 0.144 DBMET00003 0.177 0.144 DBMET00004 0.177 0.144 DBMET01588 | DB12243 | |
| 0.09 | 0.055 | 0.09 | Androgen antagonist | 0.076 0.07 DB12243 | ||
| 0.1 | 0.067 | 0.141 | GABA C receptor agonist | 0.141 0.038 DB12243 0.118 0.051 DBMET00003 0.109 0.058 DBMET00004 0.118 0.051 DBMET01588 | DB12243 | |
| 0.075 | 0.043 | 0.075 | Orexin receptor 1 antagonist | |||
| 0.134 | 0.103 | 0.14 | Heat shock protein 70 antagonist | 0.137 0.086 DB12243 0.14 0.075 DBMET00004 | DBMET00004 | |
| 0.09 | 0.06 | 0.141 | Triose-phosphate isomerase inhibitor | 0.099 0.049 DB12243 0.141 0.023 DBMET00003 0.092 0.057 DBMET00004 0.141 0.023 DBMET01588 | DBMET01588 | |
| 0.038 | 0.008 | 0.038 | Prostaglandin EP1 antagonist | |||
| 0.114 | 0.086 | 0.128 | DNA repair enzyme inhibitor | 0.128 0.057 DBMET00003 0.128 0.057 DBMET01588 | DBMET01588 | |
| 0.051 | 0.024 | 0.06 | Benzodiazepine inverse agonist | 0.059 0.015 DB12243 0.06 0.014 DBMET00003 0.06 0.014 DBMET01588 | DBMET01588 | |
| 0.059 | 0.033 | 0.066 | Phosphodiesterase II inhibitor | 0.066 0.026 DBMET00003 0.066 0.026 DBMET01588 | DBMET01588 | |
| 0.062 | 0.037 | 0.062 | Phosphodiesterase 1A inhibitor | |||
| 0.084 | 0.06 | 0.108 | Myeloperoxidase inhibitor | 0.108 0.027 DB12243 0.104 0.031 DBMET00003 0.077 0.073 DBMET00004 0.104 0.031 DBMET01588 | DB12243 | |
| 0.086 | 0.063 | 0.125 | NADH dehydrogenase inhibitor | 0.091 0.056 DB12243 0.125 0.026 DBMET00003 0.095 0.049 DBMET00004 0.125 0.026 DBMET01588 | DBMET01588 | |
| 0.132 | 0.109 | 0.197 | Heat shock protein 90 alpha antagonist | 0.197 0.051 DB12243 | DB12243 | |
| 0.224 | 0.202 | 0.317 | Antibacterial | 0.317 0.123 DBMET00003 0.317 0.123 DBMET01588 | DBMET01588 | |
| 0.143 | 0.121 | 0.143 | Pyruvate kinase inhibitor | |||
| 0.058 | 0.037 | 0.061 | Carbonic anhydrase VB inhibitor | 0.049 0.046 DB12243 0.061 0.034 DBMET00003 0.061 0.034 DBMET01588 | DBMET01588 | |
| 0.178 | 0.157 | 0.178 | 5 Hydroxytryptamine 1E antagonist | 0.177 0.158 DB12243 | ||
| 0.171 | 0.15 | 0.2 | RNA-directed DNA polymerase inhibitor | 0.186 0.122 DB12243 0.2 0.099 DBMET00003 0.189 0.117 DBMET00004 0.2 0.099 DBMET01588 | DBMET01588 | |
| 0.052 | 0.032 | 0.058 | Phosphodiesterase 2A inhibitor | 0.058 0.025 DBMET00003 0.058 0.025 DBMET01588 | DBMET01588 | |
| 0.049 | 0.028 | 0.07 | Adenylate cyclase 1 inhibitor | 0.07 0.012 DB12243 | DB12243 | |
| 0.115 | 0.098 | 0.159 | Protein kinase stimulant | 0.139 0.076 DB12243 0.159 0.062 DBMET00003 0.117 0.095 DBMET00004 0.159 0.062 DBMET01588 | DBMET01588 | |
| 0.044 | 0.027 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.009 DBMET00003 0.056 0.009 DBMET01588 | DBMET01588 | |
| 0.153 | 0.137 | 0.254 | Aldehyde oxidase inhibitor | 0.172 0.121 DB12243 0.153 0.136 DBMET00003 0.254 0.081 DBMET00004 0.153 0.136 DBMET01588 | DBMET00004 | |
| 0.019 | 0.003 | 0.019 | CD80 antagonist | 0.014 0.004 DB12243 0.017 0.004 DBMET00003 0.011 0.007 DBMET00004 0.017 0.004 DBMET01588 | ||
| 0.058 | 0.043 | 0.069 | Biliverdin reductase inhibitor | 0.065 0.036 DB12243 0.069 0.033 DBMET00003 0.069 0.033 DBMET01588 | DBMET01588 | |
| 0.108 | 0.093 | 0.153 | Cathepsin H inhibitor | 0.153 0.044 DB12243 | DB12243 | |
| 0.089 | 0.074 | 0.093 | Xanthine oxidase inhibitor | 0.093 0.067 DBMET00003 0.093 0.067 DBMET01588 | DBMET01588 | |
| 0.074 | 0.059 | 0.074 | Fibroblast growth factor 3 antagonist | |||
| 0.138 | 0.124 | 0.146 | 3C-like protease (Human coronavirus) inhibitor | 0.146 0.109 DB12243 | DB12243 | |
| 0.049 | 0.035 | 0.055 | Bromodomain-containing protein 3 inhibitor | 0.055 0.026 DB12243 | DB12243 | |
| 0.063 | 0.051 | 0.063 | Acetylcholine M5 receptor agonist | |||
| 0.062 | 0.051 | 0.062 | Aryl hydrocarbon receptor antagonist | 0.061 0.052 DB12243 | ||
| 0.084 | 0.075 | 0.099 | Prolactin inhibitor | 0.082 0.078 DB12243 0.082 0.078 DBMET00003 0.099 0.056 DBMET00004 0.082 0.078 DBMET01588 | DBMET00004 | |
| 0.061 | 0.052 | 0.062 | Transcription factor RelA inhibitor | 0.062 0.048 DB12243 0.06 0.054 DBMET00004 | DB12243 | |
| 0.11 | 0.102 | 0.11 | Growth factor antagonist | |||
| 0.051 | 0.044 | 0.056 | Bromodomain-containing protein 4 inhibitor | 0.056 0.036 DB12243 | DB12243 | |
| 0.069 | 0.061 | 0.069 | Adenosine A3 receptor antagonist | |||
| 0.012 | 0.005 | 0.012 | Corticotropin releasing factor antagonist | |||
| 0.047 | 0.04 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.035 DBMET00003 0.051 0.035 DBMET01588 | DBMET01588 | |
| 0.052 | 0.045 | 0.087 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.041 DB12243 0.087 0.018 DBMET00003 0.052 0.045 DBMET00004 0.087 0.018 DBMET01588 | DBMET01588 | |
| 0.114 | 0.108 | 0.132 | Cell wall synthesis inhibitor | 0.129 0.087 DBMET00003 0.132 0.083 DBMET00004 0.129 0.087 DBMET01588 | DBMET00004 | |
| 0.015 | 0.01 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.008 DBMET00004 | DBMET00004 | |
| 0.029 | 0.025 | 0.04 | Potassium channel small-conductance Ca-activated activator | 0.04 0.015 DB12243 | DB12243 | |
| 0.112 | 0.109 | 0.215 | Peroxidase inhibitor | 0.147 0.08 DB12243 0.113 0.108 DBMET00003 0.215 0.055 DBMET00004 0.113 0.108 DBMET01588 | DBMET00004 | |
| 0.054 | 0.052 | 0.054 | Phosphodiesterase 1B inhibitor | |||
| 0.039 | 0.038 | 0.053 | Nerve growth factor antagonist | 0.053 0.015 DB12243 | DB12243 | |
| 0.173 | 0.173 | 0.272 | Lipoxygenase inhibitor | 0.272 0.086 DB12243 0.174 0.171 DBMET00004 | DB12243 | |
| 0.05 | 0.05 | 0.056 | Dihydroorotate oxidase inhibitor | 0.056 0.036 DB12243 | DB12243 | |
| 0.077 | 0.079 | 0.091 | Estrogen-related receptor beta agonist | 0.091 0.038 DBMET00004 | DBMET00004 | |
| 0.085 | 0.088 | 0.09 | Anabolic | 0.09 0.078 DB12243 0.087 0.085 DBMET00004 | DB12243 | |
| 0.03 | 0.033 | 0.043 | Angiotensin II receptor antagonist | 0.043 0.011 DBMET00003 0.043 0.011 DBMET01588 | DBMET01588 | |
| 0.045 | 0.049 | 0.06 | Acyl-CoA dehydrogenase inhibitor | 0.06 0.033 DBMET00003 0.06 0.033 DBMET01588 | DBMET01588 | |
| 0.094 | 0.099 | 0.111 | M18 aspartyl aminopeptidase inhibitor | 0.111 0.079 DBMET00004 | DBMET00004 | |
| 0.033 | 0.038 | 0.042 | Vascular adhesion protein 1 inhibitor | 0.042 0.023 DBMET00003 0.042 0.023 DBMET01588 | DBMET01588 | |
| 0.082 | 0.088 | 0.111 | Carbonic anhydrase III inhibitor | 0.091 0.073 DB12243 0.095 0.068 DBMET00003 0.111 0.051 DBMET00004 0.095 0.068 DBMET01588 | DBMET00004 | |
| 0.033 | 0.04 | 0.047 | Glutamate (mGluR1a) antagonist | 0.047 0.023 DB12243 | DB12243 | |
| 0.081 | 0.088 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | 0.088 0.076 DB12243 | DB12243 | |
| 0.014 | 0.021 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.006 DB12243 0.018 0.011 DBMET00004 | DB12243 | |
| 0.053 | 0.063 | 0.059 | Carbonic anhydrase V inhibitor | 0.059 0.055 DBMET00003 0.059 0.055 DBMET01588 | DBMET01588 | |
| 0.068 | 0.079 | 0.08 | Glycine receptor antagonist | 0.08 0.057 DB12243 | DB12243 | |
| 0.247 | 0.257 | 0.285 | Caspase 9 stimulant | 0.284 0.212 DB12243 0.258 0.244 DBMET00003 0.285 0.211 DBMET00004 0.258 0.244 DBMET01588 | DBMET00004 | |
| 0.024 | 0.035 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.016 DBMET00004 | DBMET00004 | |
| 0.134 | 0.145 | 0.168 | Neurotensin receptor agonist | 0.168 0.066 DB12243 0.147 0.108 DBMET00004 | DB12243 | |
| 0.041 | 0.053 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.024 DB12243 0.049 0.034 DBMET00004 | DB12243 | |
| 0.04 | 0.052 | 0.06 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 DB12243 0.06 0.019 DBMET00003 0.06 0.019 DBMET01588 | DBMET01588 | |
| 0.05 | 0.063 | 0.069 | Purinergic P2X1 antagonist | 0.064 0.038 DB12243 0.069 0.033 DBMET00004 | DBMET00004 | |
| 0.064 | 0.077 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.042 DB12243 | DB12243 | |
| 0.074 | 0.088 | 0.089 | D-Ala-D-Ala ligase inhibitor | 0.089 0.046 DBMET00004 | DBMET00004 | |
| 0.043 | 0.057 | 0.053 | Adenosine A1 receptor antagonist | 0.053 0.046 DB12243 0.051 0.048 DBMET00003 0.051 0.048 DBMET01588 | DB12243 | |
| 0.047 | 0.061 | 0.075 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.045 DB12243 0.075 0.031 DBMET00003 0.075 0.031 DBMET01588 | DBMET01588 | |
| 0.06 | 0.074 | 0.07 | Exportin-1 inhibitor | 0.07 0.043 DB12243 | DB12243 | |
| 0.06 | 0.075 | 0.07 | Glutamate dehydrogenase inhibitor | 0.07 0.056 DBMET00003 0.067 0.061 DBMET00004 0.07 0.056 DBMET01588 | DBMET01588 | |
| 0.051 | 0.067 | 0.068 | Sphingosine 1-phosphate receptor 4 agonist | 0.068 0.046 DBMET00003 0.068 0.046 DBMET01588 | DBMET01588 | |
| 0.083 | 0.099 | 0.098 | Carbonic anhydrase XV inhibitor | 0.098 0.069 DBMET00003 0.094 0.076 DBMET00004 0.098 0.069 DBMET01588 | DBMET01588 | |
| 0.084 | 0.101 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.026 DB12243 | DB12243 | |
| 0.104 | 0.122 | 0.122 | Cytidine deaminase inhibitor | 0.122 0.098 DB12243 | DB12243 | |
| 0.023 | 0.043 | 0.028 | Glucosylceramidase stimulant | 0.028 0.018 DB12243 | DB12243 | |
| 0.113 | 0.134 | 0.41 | Mcl-1 antagonist | 0.41 0.01 DBMET00003 0.41 0.01 DBMET01588 | DBMET01588 | |
| 0.121 | 0.142 | 0.148 | CF transmembrane conductance regulator agonist | 0.148 0.079 DB12243 0.136 0.104 DBMET00004 | DB12243 | |
| 0.04 | 0.061 | 0.049 | Aconitate hydratase inhibitor | 0.049 0.04 DB12243 0.048 0.042 DBMET00003 0.048 0.042 DBMET01588 | DB12243 | |
| 0.034 | 0.056 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.025 DBMET00004 | DBMET00004 | |
| 0.059 | 0.081 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 DB12243 | DB12243 | |
| 0.06 | 0.082 | 0.07 | Glycine receptor agonist | 0.07 0.055 DB12243 0.07 0.055 DBMET00004 | DBMET00004 | |
| 0.073 | 0.097 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.089 0.053 DB12243 0.087 0.058 DBMET00003 0.087 0.058 DBMET01588 | DB12243 | |
| 0.036 | 0.062 | 0.062 | Aldosterone antagonist | 0.062 0.018 DB12243 | DB12243 | |
| 0.09 | 0.116 | 0.112 | Aldehyde dehydrogenase inhibitor | 0.103 0.093 DBMET00003 0.112 0.08 DBMET00004 0.103 0.093 DBMET01588 | DBMET00004 | |
| 0.048 | 0.074 | 0.058 | Pregnane X receptor antagonist | 0.058 0.035 DB12243 | DB12243 | |
| 0.038 | 0.065 | 0.105 | GABA A receptor antagonist | 0.105 0.015 DB12243 | DB12243 | |
| 0.026 | 0.053 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.028 DB12243 | DB12243 | |
| 0.066 | 0.095 | 0.089 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.089 0.058 DBMET00003 0.089 0.058 DBMET01588 | DBMET01588 | |
| 0.046 | 0.076 | 0.086 | Phosphofructokinase-1 inhibitor | 0.086 0.038 DBMET00003 0.086 0.038 DBMET01588 | DBMET01588 | |
| 0.037 | 0.068 | 0.056 | Alcohol oxidase inhibitor | 0.052 0.043 DB12243 0.056 0.039 DBMET00004 | DBMET00004 | |
| 0.116 | 0.147 | 0.131 | MAP kinase 3 inhibitor | 0.131 0.105 DBMET00003 0.131 0.105 DBMET01588 | DBMET01588 | |
| 0.112 | 0.145 | 0.134 | Adenylate cyclase stimulant | 0.13 0.102 DB12243 0.134 0.093 DBMET00004 | DBMET00004 | |
| 0.047 | 0.081 | 0.074 | Phenylalanine 4-hydroxylase inhibitor | 0.074 0.043 DBMET00004 | DBMET00004 | |
| 0.028 | 0.063 | 0.038 | Glutamate (mGluR8) agonist | 0.038 0.025 DB12243 | DB12243 | |
| 0.073 | 0.108 | 0.086 | Protein kinase C zeta inhibitor | 0.086 0.073 DB12243 | DB12243 | |
| 0.047 | 0.082 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.031 DB12243 | DB12243 | |
| 0.034 | 0.07 | 0.044 | Cholesterol esterase inhibitor | 0.044 0.041 DB12243 | DB12243 | |
| 0.048 | 0.084 | 0.064 | Carbonic anhydrase VA inhibitor | 0.064 0.054 DBMET00003 0.064 0.054 DBMET01588 | DBMET01588 | |
| 0.036 | 0.072 | 0.142 | GABA receptor antagonist | 0.142 0.01 DB12243 | DB12243 | |
| 0.156 | 0.192 | 0.21 | DNA synthesis inhibitor | 0.21 0.109 DBMET00003 0.184 0.148 DBMET00004 0.21 0.109 DBMET01588 | DBMET01588 | |
| 0.033 | 0.07 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 DBMET00003 0.039 0.029 DBMET00004 0.041 0.024 DBMET01588 | DBMET01588 | |
| 0.013 | 0.052 | 0.026 | Uridine phosphorylase inhibitor | 0.026 0.022 DBMET00003 0.026 0.022 DBMET01588 | DBMET01588 | |
| 0.049 | 0.092 | 0.068 | Glutamate decarboxylase inhibitor | 0.068 0.058 DBMET00004 | DBMET00004 | |
| 0.028 | 0.072 | 0.043 | Glutamate (mGluR group III) agonist | 0.043 0.03 DB12243 | DB12243 | |
| 0.065 | 0.11 | 0.083 | Potassium channel activator | 0.083 0.071 DB12243 | DB12243 | |
| 0.053 | 0.101 | 0.066 | Calcium channel P-type blocker | 0.066 0.037 DB12243 | DB12243 | |
| 0.037 | 0.085 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.028 DB12243 | DB12243 | |
| 0.061 | 0.11 | 0.294 | GABA A receptor agonist | 0.294 0.005 DB12243 | DB12243 | |
| 0.024 | 0.073 | 0.06 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET00003 0.06 0.021 DBMET01588 | DBMET01588 | |
| 0.12 | 0.171 | 0.142 | ATPase inhibitor | 0.142 0.116 DB12243 | DB12243 | |
| 0.107 | 0.159 | 0.132 | Neuropeptide Y1 antagonist | 0.132 0.096 DB12243 | DB12243 | |
| 0.108 | 0.163 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | 0.135 0.089 DB12243 | DB12243 | |
| 0.024 | 0.08 | 0.075 | AMPA receptor antagonist | 0.075 0.019 DB12243 | DB12243 | |
| 0.109 | 0.166 | 0.138 | Anesthetic general | 0.138 0.127 DBMET00004 | DBMET00004 | |
| 0.042 | 0.099 | 0.067 | NMDA receptor agonist | 0.067 0.039 DB12243 | DB12243 | |
| 0.065 | 0.123 | 0.081 | mTOR complex 2 inhibitor | 0.081 0.067 DB12243 | DB12243 | |
| 0.07 | 0.129 | 0.366 | GABA receptor agonist | 0.366 0.005 DB12243 | DB12243 | |
| 0.029 | 0.089 | 0.12 | Glutamate (mGluR1) antagonist | 0.12 0.011 DB12243 | DB12243 | |
| 0.058 | 0.122 | 0.07 | GABA B receptor agonist | 0.07 0.069 DB12243 | DB12243 | |
| 0.107 | 0.172 | 0.136 | Interferon gamma antagonist | 0.136 0.099 DB12243 | DB12243 | |
| 0.105 | 0.171 | 0.138 | Amyloid beta precursor protein antagonist | 0.138 0.116 DBMET00004 | DBMET00004 | |
| 0.023 | 0.09 | 0.1 | Carbonic anhydrase I inhibitor | 0.1 0.018 DB12243 | DB12243 | |
| 0.061 | 0.129 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.071 DBMET00004 | DBMET00004 | |
| 0.015 | 0.083 | 0.027 | Glutamate (mGluR2) antagonist | 0.027 0.025 DB12243 | DB12243 | |
| 0.096 | 0.166 | 0.155 | Heat shock protein 90 antagonist | 0.155 0.069 DB12243 | DB12243 | |
| 0.148 | 0.225 | 0.196 | Cholesterol antagonist | 0.191 0.173 DBMET00003 0.196 0.168 DBMET00004 0.191 0.173 DBMET01588 | DBMET00004 | |
| 0.022 | 0.099 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.031 DB12243 | DB12243 | |
| 0.02 | 0.097 | 0.097 | Carbonic anhydrase II inhibitor | 0.097 0.019 DB12243 | DB12243 | |
| 0.042 | 0.119 | 0.069 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.069 0.062 DBMET00003 0.069 0.062 DBMET01588 | DBMET01588 | |
| 0.074 | 0.152 | 0.096 | DOPA decarboxylase inhibitor | 0.096 0.084 DBMET00004 | DBMET00004 | |
| 0.067 | 0.149 | 0.227 | Amylase inhibitor | 0.227 0.035 DB12243 0.105 0.092 DBMET00003 0.104 0.093 DBMET00004 0.105 0.092 DBMET01588 | DB12243 | |
| 0.018 | 0.1 | 0.04 | Glutamate (mGluR group II) antagonist | 0.04 0.025 DB12243 | DB12243 | |
| 0.033 | 0.116 | 0.162 | MAP kinase 11 inhibitor | 0.162 0.015 DB12243 | DB12243 | |
| 0.115 | 0.199 | 0.177 | Interleukin agonist | 0.177 0.143 DBMET00003 0.177 0.143 DBMET01588 | DBMET01588 | |
| 0.014 | 0.1 | 0.073 | Carbonic anhydrase XII inhibitor | 0.073 0.028 DB12243 | DB12243 | |
| 0.013 | 0.101 | 0.122 | Carbonic anhydrase IX inhibitor | 0.122 0.016 DB12243 | DB12243 | |
| 0.06 | 0.149 | 0.106 | Polo-like kinase-1 inhibitor | 0.106 0.039 DB12243 | DB12243 | |
| 0.027 | 0.118 | 0.049 | GABA B receptor antagonist | 0.049 0.021 DB12243 | DB12243 | |
| 0.028 | 0.12 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET00003 0.054 0.036 DBMET01588 | DBMET01588 | |
| 0.023 | 0.114 | 0.117 | Carbonic anhydrase inhibitor | 0.117 0.022 DB12243 | DB12243 | |
| 0.045 | 0.142 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 DB12243 | DB12243 | |
| 0.03 | 0.13 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 DB12243 | DB12243 | |
| 0.074 | 0.179 | 0.133 | Factor V inhibitor | 0.133 0.028 DB12243 | DB12243 | |
| 0.041 | 0.148 | 0.139 | MAO A inhibitor | 0.139 0.045 DB12243 | DB12243 | |
| 0.148 | 0.255 | 0.265 | Antithrombotic | 0.265 0.115 DB12243 0.215 0.16 DBMET00003 0.215 0.16 DBMET01588 | DB12243 | |
| 0.018 | 0.132 | 0.041 | Mannosidase inhibitor | 0.041 0.039 DBMET00003 0.041 0.039 DBMET01588 | DBMET01588 | |
| 0.021 | 0.165 | 0.06 | Phosphodiesterase VII inhibitor | 0.06 0.047 DB12243 | DB12243 | |
| 0.103 | 0.252 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.099 DBMET00004 | DBMET00004 | |
| 0.043 | 0.194 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.043 DB12243 | DB12243 | |
| 0.029 | 0.19 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | 0.059 0.032 DB12243 | DB12243 | |
| 0.125 | 0.289 | 0.208 | Neuropeptide Y2 antagonist | 0.208 0.107 DB12243 | DB12243 | |
| 0.051 | 0.217 | 0.114 | Interleukin 5 antagonist | 0.114 0.028 DB12243 | DB12243 | |
| 0.031 | 0.2 | 0.064 | Ca(v)3.2 blocker | 0.064 0.031 DB12243 | DB12243 | |
| 0.022 | 0.196 | 0.073 | MAP kinase 14 inhibitor | 0.073 0.052 DB12243 | DB12243 | |
| 0.034 | 0.216 | 0.172 | MAO inhibitor | 0.172 0.051 DB12243 | DB12243 | |
| 0.083 | 0.266 | 0.642 | Free radical scavenger | 0.642 0.007 DB12243 | DB12243 | |
| 0.018 | 0.213 | 0.133 | MAO B inhibitor | 0.133 0.044 DB12243 | DB12243 | |
| 0.044 | 0.25 | 0.221 | MAP kinase 12 inhibitor | 0.221 0.017 DB12243 | DB12243 | |
| 0.027 | 0.245 | 0.064 | Glutamate (mGluR group I) antagonist | 0.064 0.058 DB12243 | DB12243 | |
| 0.043 | 0.269 | 0.162 | Phosphodiesterase inhibitor | 0.162 0.051 DB12243 | DB12243 | |
| 0.019 | 0.266 | 0.141 | Phosphodiesterase IV inhibitor | 0.141 0.025 DB12243 | DB12243 | |
| 0.116 | 0.368 | 0.248 | Apoptosis antagonist | 0.248 0.129 DBMET00003 0.248 0.129 DBMET01588 | DBMET01588 | |
| 0.047 | 0.31 | 0.102 | Ca(v)3.1 blocker | 0.102 0.021 DB12243 | DB12243 | |
| 0.016 | 0.287 | 0.098 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.098 0.036 DB12243 | DB12243 | |
| 0.073 | 0.377 | 0.218 | Transcription factor NF kappa B inhibitor | 0.218 0.152 DB12243 | DB12243 | |
| 0.035 | 0.341 | 0.117 | MAP kinase 13 inhibitor | 0.117 0.059 DB12243 | DB12243 | |
| 0.02 | 0.34 | 0.1 | Phosphodiesterase 3A inhibitor | 0.1 0.032 DB12243 | DB12243 | |
| 0.106 | 0.452 | 0.262 | Interleukin 2 agonist | 0.262 0.105 DBMET00003 0.262 0.105 DBMET01588 | DBMET01588 | |
| 0.042 | 0.416 | 0.088 | 3C-Like protease (SARS coronavirus) inhibitor | 0.088 0.05 DB12243 | DB12243 | |
| 0.039 | 0.441 | 0.343 | Antiamyloidogenic | 0.343 0.041 DB12243 | DB12243 | |
| 0.023 | 0.435 | 0.117 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.117 0.104 DB12243 | DB12243 | |
| 0.01 | 0.466 | 0.142 | GHS receptor antagonist | 0.142 0.004 DB12243 | DB12243 | |
| 0.019 | 0.51 | 0.286 | Telomerase inhibitor | 0.286 0.007 DB12243 | DB12243 | |
| 0.017 | 0.513 | 0.126 | Neurotrophic factor | 0.126 0.086 DB12243 | DB12243 | |
| 0.009 | 0.516 | 0.144 | 5-Lipoxygenase inhibitor | 0.144 0.04 DB12243 | DB12243 | |
| 0.03 | 0.539 | 0.374 | Vasodilator | 0.374 0.028 DB12243 | DB12243 | |
| 0.048 | 0.56 | 0.309 | Hypoglycemic | 0.309 0.05 DBMET00004 | DBMET00004 | |
| 0.03 | 0.542 | 0.412 | Antioxidant | 0.412 0.033 DB12243 | DB12243 | |
| 0.005 | 0.527 | 0.047 | Acetyl-CoA transferase 1 inhibitor | 0.047 0.021 DB12243 | DB12243 | |
| 0.01 | 0.539 | 0.099 | Glutamate receptor antagonist | 0.099 0.098 DB12243 | DB12243 | |
| 0.008 | 0.592 | 0.265 | HIV-1 integrase inhibitor | 0.265 0.004 DBMET00004 | DBMET00004 | |
| 0.018 | 0.603 | 0.169 | DNA directed RNA polymerase inhibitor | 0.169 0.019 DBMET00004 | DBMET00004 | |
| 0.008 | 0.625 | 0.088 | Nitric oxide donor | 0.088 0.016 DB12243 | DB12243 | |
| 0.004 | 0.624 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | 0.028 0.018 DB12243 | DB12243 | |
| 0.006 | 0.63 | 0.071 | Lipase inhibitor | 0.071 0.053 DBMET00004 | DBMET00004 | |
| 0.041 | 0.683 | 0.412 | Apoptosis agonist | 0.412 0.108 DBMET00003 0.412 0.108 DBMET01588 | DBMET01588 | |
| 0.003 | 0.667 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 DBMET00004 | DBMET00004 | |
| 0.006 | 0.753 | 0.094 | Bronchodilator | 0.094 0.071 DB12243 | DB12243 | |
| 0.019 | 0.808 | 0.264 | Immunomodulator | 0.264 0.104 DBMET00003 0.264 0.104 DBMET01588 | DBMET01588 | |
| 0.017 | 0.811 | 0.379 | Cyclophilin D inhibitor | 0.379 0.103 DBMET00003 0.379 0.103 DBMET01588 | DBMET01588 | |
| 0.009 | 0.87 | 0.961 | Amyloid beta aggregation inhibitor | 0.961 0.003 DB12243 | DB12243 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |